ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ANEB Anebulo Pharmaceuticals Inc

2.95
-0.17 (-5.45%)
04 May 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -1.88M-2.33M-2.61M-3.81M-2.86M-2.49M-2.54M-2.76M
Pre Tax Income -1.88M-2.32M-2.61M-3.83M-2.8M-2.5M-2.48M-2.72M
Net Income -1.88M-2.32M-2.61M-3.83M-2.8M-2.5M-2.48M-2.72M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -1.88M-2.33M-2.61M-3.83M-2.81M-2.54M-2.54M-2.76M
EBITDA -1.88M-2.33M-2.61M-3.81M-2.86M-2.49M-2.54M-2.76M
Year End 30 June 2023 2020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 0000
Operating Income -174k-3.61M-6.83M-11.78M
Pre Tax Income -175k-30.25M-6.83M-11.73M
Net Income -175k-38.46M-6.83M-11.73M
Preferred Dividends 0-8.21M00
Basic Earnings Per Share (EPS) -0.088-1.515-0.269-0.424
EBIT -174k-3.62M-6.83M-11.82M
EBITDA -174k-3.61M-6.83M-11.78M

Your Recent History

Delayed Upgrade Clock